Fresenius | FRE - Ebitda

Stock Price
38.80
Daily Change
-0.27 -0.69%
Monthly
-13.04%
Yearly
-10.43%
Q2 Forecast
37.79

Fresenius reported EUR951M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 795M 478M Mar/2026
AstraZeneca USD 5.67B 1.29B Mar/2026
BASF EUR 2.36B 217M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
DaVita Healthcare Partners USD 659.83M 112.87M Mar/2026
Demant DKK 2.76B 165M Dec/2025
E.ON EUR 2.83B 1.05B Dec/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Getinge SEK 3.47B 2.13B Dec/2024
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GN Store Nord DKK 491M 136M Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 5.3B 530M Mar/2026
Philips EUR 567M 233M Mar/2026
Roche Holding CHF 12.68B 2.36B Jun/2024
RWE EUR 1.63B 20M Mar/2026
Sanofi EUR 3.31B 3.65B Mar/2026
Smith & Nephew USD 796M 139M Dec/2025